However, the evidence is still evolving related to how these medications may impact complications related to obesity such as heart disease and diabetes. The Pharmaceutical Strategies Group (PSG), a pharmaceutical management consulting company, surveyed 180 benefits executives representing health plans, employers and unions and found that these drugs are a major concern
Medications in clinical trials which are under investigation for treating type 2 diabetes mellitus and/or obesity commonly target two-three receptors
No hormone-related therapy should be considered automatically safer without a proper medical evaluation
These findings not only confirm the antioxidative protective effects of MSCs under hypoxic high-altitude conditions but also suggest that they may counteract oxidative damage through multiple signaling pathways
These are the top 10 supplements for brain healthfrom ashwagandha to zeaxanthin
doi: 10.3389/fphar.2025.1591825 Received 11 March 2025 Accepted 28 August 2025 Published 08 October 2025 Volume 16 - 2025 Edited by Er Sheng Gong, Gannan Medical University, China Reviewed by Guillermo Federico Spitzmaul, National Scientific and Technical Research Council (CONICET), Argentina Leonardo Dionisio, National Scientific and Technical Research Council (CONICET), Argentina Updates Copyright 2025 Giannini, Soldi, Elli, Sagheddu, Castagnetti, Viciani, Salvini, Battistuzzi, Milazzo, Alibrandi and Sidoti